Showing results (841-850 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACsDuncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Identification and Development of 1,4-Diaryl-1,2,3-triazolo-Based Ureas as Novel FLT3 InhibitorsJisheng Liu, Yuting Wang, Chen Chen, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) FamilyAlex Preston, Stephen J Atkinson, Paul Bamborough, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Toward the Target: Tilorone, Quinacrine, and Pyronaridine Bind to Ebola Virus GlycoproteinThomas R Lane, Sean Ekins
ACS Medicinal Chemistry Letters|April 16, 2021
Identification of Piperidine-3-carboxamide Derivatives Inducing Senescence-like Phenotype with Antimelanoma ActivitiesSangmi Oh, Do Yoon Kwon, Inhee Choi, et al.
ACS Medicinal Chemistry Letters|October 18, 2012
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action StudiesChris Dockendorff, Marek M Nagiec, Michel Weïwer, et al.
ACS Medicinal Chemistry Letters|October 11, 2012
Thermodynamic Investigation of Inhibitor Binding to 1-Deoxy-D-Xylulose-5-Phosphate ReductoisomeraseGuobin Cai, Lisheng Deng, Bartlomiej G Fryszczyn, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Proline Homologation in Melanostatin Neuropeptide: Discovery of Potent Modulators of the Dopamine D2 ReceptorsIvo E Sampaio-Dias, Hugo F Costa-Almeida, Xavier C Correia, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|August 20, 2025
Structure-Activity Relationship Study of Benzamides as Mycobacterium tuberculosis QcrB InhibitorsBrock E Lynde, Jared Mattos, Danielle M Chemaly, et al.
Pageof 438